Importantly, genetic inhibition of ZDHHCs (ZDHHC3, 5, 17, 9, 12) has revealed significant therapeutic efficacy in some animal tumor models, including colon cancer, glioblastoma, leukemia, and ovarian cancer. This evidence concerns the gene ZDHHC3 and glioblastoma.